Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dojindo Laboratories is a prominent Japanese manufacturer of chemical reagents and assay kits for life science research. The company is best known for developing the Cell Counting Kit-8 (CCK-8), a gold-standard tool for measuring cell viability and proliferation. Their expertise lies in the synthesis of chromogenic and fluorogenic probes, chelating agents, and specialized kits for studying oxidative stress, metabolism, and cellular signaling. Headquartered in Kumamoto, Japan, Dojindo supports global research through its subsidiaries in the United States, Europe, and China. The company's products are essential for researchers in oncology, immunology, and metabolic disease studies. Dojindo continues to innovate in the field of molecular imaging and biochemical analysis tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemical Dojin.